FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W56467351> ?p ?o ?g. }

• W56467351 abstract "Even with the advent of shorter-acting muscle relaxants, the risk of residual blockade continues to persist. Consequently, in daily practice, we are confronted with the following contradiction, namely, how best to combine muscular relaxation throughout the operative procedure without exposing patients to the risk of residual blockade at the end of the case. A Continuing Professional Development (CPD) module concerning residual blockade is published in this issue of the Journal. Why was it necessary to publish a CPD module on this topic when a number of related studies and surveys reports are already available? While many clinicians are convinced about the benefits of both neuromuscular monitoring and reversal in current practice, nevertheless, reality seems to differ. Anesthesiologists are well trained in the use of neuromuscular blocking agents. In fact, anesthesiology is the only specialty where these drugs are routinely used. And yet, many clinicians tend not to follow the basic recommendations for using both neuromuscular monitoring and reversal agents. The circumstances leading to this state of affairs are likely more complex. The last updated version of the American Society of Anesthesiologists’ (ASA) Practice Guidelines for Postanesthetic Care states that: ‘‘Assessment of neuromuscular function primarily includes physical examination and, on occasion, may include neuromuscular blockade monitoring’’. With such an assertion regarding the potential for occasional use of neuromuscular monitoring, it would, in all likelihood, be difficult to convince our colleagues regarding the benefits of neuromuscular monitoring and modify existing behaviour. Clinical methods for determining signs of residual blockade may not have the degree of sensitivity to detect partial paralysis. For example, residual paralysis is likely in patients who are able to maintain a sustained head lift. It is only with objective neuromuscular monitoring that one can exclude residual blockade. Clearly, the ASA Task Force on Postanesthetic Care developed their recommendation based on data lacking in sufficient evidence. This is also the basis for SpO2 monitoring. Pedersen et al. from the Cochrane Collaboration updated the systematic review on the use of pulse oximetry during the perioperative period. The authors’ conclusions are comparable with two previous reviews published by the same group. Even if the use of pulse oximetry helped decrease the frequency of hypoxemic episodes, it does not influence patient outcome on major end points (e.g., death and cardiovascular, respiratory, or neurological complications). Even when we consider these evidence-based data on pulse oximetry, can any one of us imagine starting a case without its use? This depiction reveals the limits of evidence-based medicine. This topic has previously been addressed with humour in a study on whether or not there are benefits to using a parachute to prevent death during free fall. Residual blockade remains a specific concern in daily anesthesia practice. The use of neuromuscular blocking drugs has facilitated major progress in performing additional and more complex surgical procedures. This view was first addressed by Dr. Harrold Griffith et al. 70 years ago when Benoit Plaud is consultant for MSD France and MSD International and has participated in the clinical development of sugammadex (Bridion )." @default.
• W56467351 created "2016-06-24" @default.
• W56467351 creator A5040485712 @default.
• W56467351 date "2013-05-10" @default.
• W56467351 modified "2023-10-10" @default.
• W56467351 title "Neuromuscular monitoring, residual blockade, and reversal: Time for re-evaluation of our clinical practice" @default.
• W56467351 cites W137212124 @default.
• W56467351 cites W1523416016 @default.
• W56467351 cites W1987374560 @default.
• W56467351 cites W1994307831 @default.
• W56467351 cites W1996232615 @default.
• W56467351 cites W2029563885 @default.
• W56467351 cites W2045332614 @default.
• W56467351 cites W2054572081 @default.
• W56467351 cites W2060129272 @default.
• W56467351 cites W2076327878 @default.
• W56467351 cites W2107138208 @default.
• W56467351 cites W2109495812 @default.
• W56467351 cites W2126612510 @default.
• W56467351 cites W2131776257 @default.
• W56467351 cites W2139026464 @default.
• W56467351 cites W2141888832 @default.
• W56467351 cites W2147773646 @default.
• W56467351 cites W2152365807 @default.
• W56467351 cites W2154734472 @default.
• W56467351 cites W2169189741 @default.
• W56467351 doi "https://doi.org/10.1007/s12630-013-9952-4" @default.
• W56467351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23661296" @default.
• W56467351 hasPublicationYear "2013" @default.
• W56467351 type Work @default.
• W56467351 sameAs 56467351 @default.
• W56467351 citedByCount "5" @default.
• W56467351 countsByYear W564673512013 @default.
• W56467351 countsByYear W564673512015 @default.
• W56467351 countsByYear W564673512016 @default.
• W56467351 countsByYear W564673512017 @default.
• W56467351 countsByYear W564673512019 @default.
• W56467351 crossrefType "journal-article" @default.
• W56467351 hasAuthorship W56467351A5040485712 @default.
• W56467351 hasBestOaLocation W564673511 @default.
• W56467351 hasConcept C126322002 @default.
• W56467351 hasConcept C170493617 @default.
• W56467351 hasConcept C177713679 @default.
• W56467351 hasConcept C206044474 @default.
• W56467351 hasConcept C2778468042 @default.
• W56467351 hasConcept C2779526319 @default.
• W56467351 hasConcept C2909465803 @default.
• W56467351 hasConcept C2910841738 @default.
• W56467351 hasConcept C42219234 @default.
• W56467351 hasConcept C71924100 @default.
• W56467351 hasConceptScore W56467351C126322002 @default.
• W56467351 hasConceptScore W56467351C170493617 @default.
• W56467351 hasConceptScore W56467351C177713679 @default.
• W56467351 hasConceptScore W56467351C206044474 @default.
• W56467351 hasConceptScore W56467351C2778468042 @default.
• W56467351 hasConceptScore W56467351C2779526319 @default.
• W56467351 hasConceptScore W56467351C2909465803 @default.
• W56467351 hasConceptScore W56467351C2910841738 @default.
• W56467351 hasConceptScore W56467351C42219234 @default.
• W56467351 hasConceptScore W56467351C71924100 @default.
• W56467351 hasLocation W564673511 @default.
• W56467351 hasLocation W564673512 @default.
• W56467351 hasOpenAccess W56467351 @default.
• W56467351 hasPrimaryLocation W564673511 @default.
• W56467351 hasRelatedWork W1452502418 @default.
• W56467351 hasRelatedWork W1517845994 @default.
• W56467351 hasRelatedWork W1562655512 @default.
• W56467351 hasRelatedWork W178301698 @default.
• W56467351 hasRelatedWork W1823792488 @default.
• W56467351 hasRelatedWork W2011384753 @default.
• W56467351 hasRelatedWork W2046309036 @default.
• W56467351 hasRelatedWork W2047856487 @default.
• W56467351 hasRelatedWork W2079801166 @default.
• W56467351 hasRelatedWork W2082825886 @default.
• W56467351 hasRelatedWork W2086922051 @default.
• W56467351 hasRelatedWork W2131495599 @default.
• W56467351 hasRelatedWork W2164512471 @default.
• W56467351 hasRelatedWork W2211977052 @default.
• W56467351 hasRelatedWork W2322646185 @default.
• W56467351 hasRelatedWork W2426437122 @default.
• W56467351 hasRelatedWork W2551902803 @default.
• W56467351 hasRelatedWork W2583408433 @default.
• W56467351 hasRelatedWork W309499401 @default.
• W56467351 hasRelatedWork W2172197329 @default.
• W56467351 isParatext "false" @default.
• W56467351 isRetracted "false" @default.
• W56467351 magId "56467351" @default.
• W56467351 workType "article" @default.